Multisystem Processes & Disorders

Botulism: foodborne, wound, infant

Clinical Overview and When to Suspect Botulism

— Affects both somatic neuromuscular junctions (flaccid paralysis) and autonomic synapses (anticholinergic-like symptoms: dry mouth, ileus, mydriasis, urinary retention)

— Foodborne: preformed toxin ingested (home-canned vegetables, fermented fish, smoked/preserved meats); incubation 12–36 h

— Wound: in vivo toxin production from contaminated wound; classic in black tar heroin "skin poppers" and traumatic crush wounds; incubation 4–14 days

— Infant (<12 months): ingestion of spores (honey, soil, dust) that germinate in immature gut; the most common form in the US

— Pediatric: floppy infant with poor feeding, weak cry, constipation

— IVDU with cranial nerve palsies and a wound → wound botulism

Botulism is a neuroparalytic illness caused by toxins (most commonly types A, B, E) from Clostridium botulinum, a gram-positive, spore-forming anaerobe

Toxin mechanism: irreversibly cleaves SNARE proteins (SNAP-25, syntaxin, synaptobrevin) at the presynaptic cholinergic terminal, blocking acetylcholine release

Three classic exam forms to recognize on Step 3:

Other forms worth knowing: iatrogenic (cosmetic/therapeutic toxin overdose), adult intestinal colonization (post-GI surgery, IBD), inhalational (bioterrorism)

When to suspect: acute, symmetric, descending flaccid paralysis beginning with bulbar symptoms (diplopia, dysarthria, dysphagia, ptosis) in an afebrile, alert patient with intact sensation

Board pearl: The classic tetrad is "4 D's" — diplopia, dysarthria, dysphonia, dysphagia — followed by symmetric descending weakness with preserved sensation and mentation

Step 3 management: Suspicion alone triggers immediate state/local health department notification and antitoxin request — do NOT wait for labs, because antitoxin only halts progression; it cannot reverse existing paralysis

Presentation Patterns and Key History

— Onset 12–36 h (range 6 h–10 d) after eating improperly preserved home-canned low-acid foods (green beans, asparagus, corn, beets), fermented seafood (Alaska Native communities, type E), garlic-in-oil, or contaminated commercial products

— GI prodrome: nausea, vomiting, abdominal cramps, diarrhea then constipation

— Multiple household members often affected — cluster history is a huge clue

— Onset 4–14 days after inoculation

— High-yield exposures: subcutaneous "skin-popping" of black tar heroin, open fractures, sinusitis from intranasal cocaine, postpartum/postsurgical wounds

— No GI prodrome (toxin is produced systemically, not ingested); fever may be present from secondary wound infection

— Age <12 months, peak 2–4 months

— Constipation is often the first symptom (precedes neuro signs by days), then poor feeding, weak suck, weak cry, hypotonia ("floppy baby"), ptosis, sluggish pupils, loss of head control

— Exposures: honey (classic), corn syrup, environmental soil/dust (construction sites, rural areas, California, Pennsylvania, Utah have highest rates)

— Recent home-canned, fermented, or vacuum-packaged foods; group meals?

— IV/SC drug use, recent wounds, dental abscess?

— Honey or herbal teas given to infant; new house construction/dust exposure?

— Recent cosmetic botulinum toxin injection (iatrogenic form)?

Foodborne botulism

Wound botulism

Infant botulism

Key historical questions to elicit on every suspected case:

Key distinction: Sensory symptoms, fever (in foodborne/infant), or asymmetric weakness should make you reconsider — botulism is classically afebrile, symmetric, motor-only, with preserved sensation and clear mentation

Board pearl: Ask about fellow diners — a single case often reveals an outbreak requiring public health response

Physical Exam Findings and Bedside Assessment

— Bilateral ptosis, ophthalmoplegia, fixed dilated or sluggishly reactive pupils (~50%), diplopia

— Facial weakness, dysarthria, dysphagia, suppressed gag

— Tongue weakness; pooled secretions

— Begins in neck/shoulders → proximal arms → diaphragm/intercostals → lower extremities

— Deep tendon reflexes initially preserved, become diminished as paralysis worsens (helps distinguish from GBS where reflexes are lost early)

— No sensory deficits; mental status clear (toxin does not cross BBB)

— Dry mouth, dry eyes, ileus, urinary retention, orthostatic hypotension, fixed heart rate

— Monitor negative inspiratory force (NIF) and forced vital capacity (FVC)

— Intubate when NIF worse than –20 to –30 cmH₂O or FVC <30% predicted (~<15–20 mL/kg), or if single-breath count <20, or for inability to handle secretions

— Do not wait for hypoxia/hypercapnia — they are late findings

Cranial nerve findings dominate early:

Descending symmetric flaccid weakness:

Autonomic / anticholinergic-like signs (from parasympathetic cholinergic blockade):

Respiratory assessment is the single most important bedside task:

Infant exam specifics: head lag, decreased anal tone, "doll-like" facies, ptosis, sluggish pupils, decreased gag, weak cry

CCS pearl: Order continuous pulse oximetry, capnography, and serial bedside spirometry every 2–4 hours; if FVC trending down, call anesthesia early for elective semi-upright intubation before respiratory arrest

Board pearl: The exam triad of symmetric bulbar palsies + descending weakness + normal sensorium with dilated pupils in an afebrile patient is essentially pathognomonic on Step 3 stems

Diagnostic Workup — Initial Labs, Imaging, Bedside Studies

— CBC: normal (leukocytosis suggests alternative dx or wound superinfection)

— BMP, LFTs, CK: largely unremarkable

— ABG: late hypercapnia signals impending respiratory failure

— Lactate, troponin as clinically indicated

— Serial NIF, FVC, single-breath count

— Continuous SpO₂, end-tidal CO₂

— Botulism CSF: normal (no albuminocytologic dissociation)

— GBS CSF: elevated protein with normal WBC (after ~1 week)

— In ileus/constipation, an enema with sterile non-bacteriostatic water may be needed to obtain a sample (avoid saline — interferes with mouse bioassay)

Botulism is a clinical diagnosis — empiric treatment must precede confirmatory testing

Routine labs are typically normal and serve mainly to exclude mimics:

Bedside pulmonary metrics (the most actionable data):

Lumbar puncture: indicated when GBS or meningoencephalitis is on the differential

Neuroimaging (CT/MRI brain): obtain if stroke, brainstem lesion, or basilar artery thrombosis is in the differential — should be normal in botulism

ECG: usually normal; rule out cardiac causes of weakness/syncope

Stool studies (foodborne and infant): collect stool for toxin assay and C. botulinum culture — gold standard for infant botulism is stool toxin detection

Serum toxin assay (mouse bioassay or mass spectrometry at CDC/state lab): highest yield in foodborne within 1–2 days of ingestion

Wound cultures and toxin assay from wound exudate for wound botulism

Step 3 management: Call your state health department and CDC Emergency Operations Center (770-488-7100, 24/7) before sending samples — they coordinate testing and release antitoxin from the Strategic National Stockpile

Board pearl: Normal CSF + descending paralysis = botulism; elevated CSF protein + ascending paralysis = GBS

Diagnostic Workup — Advanced and Confirmatory Studies

— Mouse bioassay: historical gold standard; detects toxin in serum, stool, gastric contents, food, or wound exudate; takes up to 4 days

— Endopep-MS (mass spectrometry): faster, increasingly replacing mouse bioassay

— Anaerobic culture of stool/wound for C. botulinum; PCR for neurotoxin genes

— Suspect food samples should be collected and refrigerated (not frozen) for analysis

— Compound muscle action potential (CMAP) amplitudes are decreased at rest

— Incremental response (facilitation) with high-frequency repetitive nerve stimulation (≥20–50 Hz) or post-exercise — classic for presynaptic NMJ disorders

— Normal sensory studies; normal nerve conduction velocities

— Key distinction: Lambert-Eaton also shows facilitation but is subacute/chronic with proximal weakness that improves with use, plus areflexia and autonomic features; myasthenia gravis shows decrement on low-frequency (2–3 Hz) stimulation and post-tetanic facilitation but no incremental response

— Identify and trace contacts/co-ingesters

— Recover suspect food; coordinate with FDA/USDA for commercial products

— Mandatory case reporting (botulism is a nationally notifiable disease)

Confirmatory laboratory testing (performed at CDC or designated state public health labs):

Electrodiagnostic studies (EMG/NCS) — useful when diagnosis unclear or to distinguish from mimics:

Tensilon (edrophonium) test: may show mild transient improvement in botulism but is not diagnostic; reserved for myasthenia evaluation

Ice pack test: improves ptosis in myasthenia, not in botulism

Anti-AChR, anti-MuSK antibodies: send if myasthenia gravis remains plausible

Public health workup:

Step 3 management: EMG can support diagnosis but must not delay antitoxin — empiric antitoxin is given on clinical suspicion alone; confirmatory testing runs in parallel

Risk Stratification and First-Line Management Logic

— Serial NIF and FVC every 2–4 h initially

— Intubate electively when FVC <30% predicted (~15–20 mL/kg), NIF >−30 cmH₂O, inability to protect airway, or rapidly worsening bulbar function

— Anticipate prolonged mechanical ventilation (mean 2–8 weeks in foodborne; can exceed 3 months)

— Early tracheostomy consideration if prolonged ventilation expected

— Foodborne and wound (adults/children ≥1 yr): Heptavalent equine botulism antitoxin (HBAT) from CDC via state health department

— Infants (<1 yr): Human-derived Botulism Immune Globulin IV (BIG-IV, "BabyBIG") from California Infant Botulism Treatment and Prevention Program (510-231-7600)

— Foodborne: supportive; activated charcoal within ~1 h of ingestion may be considered if ileus absent; avoid emetics in paralyzed patients

— Wound: surgical debridement of the wound (even if antitoxin given) + antibiotics

— Infant: avoid aminoglycosides/clindamycin (potentiate neuromuscular blockade)

— DVT prophylaxis, stress ulcer prophylaxis, enteral nutrition once ileus resolves, eye lubrication for incomplete eyelid closure, bladder catheterization for retention, aggressive pulmonary toilet

Disposition: every suspected botulism case is admitted, almost always to an ICU with airway/ventilator capability

Airway is priority #1:

Antitoxin halts further toxin binding but cannot reverse existing paralysis — therefore earlier = better

Source control:

Supportive ICU care:

CCS pearl: Order — admit ICU, continuous cardiopulmonary monitoring, q2h NIF/FVC, NPO if dysphagic, NG decompression if ileus, call CDC/state health dept for HBAT or CIBTPP for BabyBIG, wound surgical consult if applicable, infectious disease and neurology consults

Board pearl: Antitoxin prevents progression, doesn't reverse paralysis — never delay it pending confirmatory tests

Pharmacotherapy — Antitoxin and Adjuncts

— Indications: foodborne and wound botulism in patients ≥1 year old; inhalational/bioterrorism cases

— Dose: single IV vial diluted 1:10 in normal saline; pediatric weight-based dosing per package insert

— Pre-medicate/observe for anaphylaxis and serum sickness (equine product); skin testing per package insert in those with horse/asthma history; have epinephrine, diphenhydramine, methylprednisolone at bedside

— Premedicate slow infusion rate; titrate up if tolerated

— Half-life is long enough that a single dose is generally sufficient

— For infant botulism only (<1 yr); obtained from California Infant Botulism Treatment and Prevention Program

— Single IV infusion; shortens hospital stay by ~3 weeks and reduces ventilator days; mild infusion reactions occasionally

— Wound botulism: penicillin G 3 million units IV q4h or metronidazole 500 mg IV q8h (penicillin allergic), after antitoxin administered (cell lysis releases additional toxin) + surgical debridement

— Foodborne and infant botulism: antibiotics not routinely given — they can cause toxin release from bacterial lysis and worsen disease

— Avoid aminoglycosides, clindamycin, tetracyclines, polymyxins — they impair NMJ transmission and potentiate paralysis in all forms

— Bowel regimen (avoid prokinetics with anticholinergic interactions), prophylactic LMWH, PPI/H2 blocker, careful sedation choice in intubated patients (avoid neuromuscular blockers when possible)

HBAT (Heptavalent Botulism Antitoxin, equine-derived) — covers serotypes A–G

BIG-IV (BabyBIG) — human-derived immunoglobulin against toxins A and B

Antibiotics:

Supportive pharmacology:

Step 3 management: A heroin user with wound botulism gets HBAT first, then penicillin G + surgical debridement — order matters; antitoxin precedes lytic antibiotics

Procedures and Supportive Critical Care

— Pre-oxygenate; perform semi-elective intubation before crisis

— Use video laryngoscopy if available; avoid succinylcholine if hyperkalemia risk; rocuronium dosing may need reduction due to receptor sensitivity in NMJ disease

— Anticipate prolonged ventilation; plan tracheostomy at ~10–14 days if no extubation trajectory

— Volume-controlled or pressure-controlled with lung-protective settings (Vt 6–8 mL/kg IBW)

— Daily spontaneous breathing trials are unrewarding early; extubation typically requires recovery of bulbar function (cough, gag, secretion handling) more than spirometric numbers alone

— Surgical I&D of all suspected wounds — including innocuous-appearing injection sites — with cultures sent for anaerobes and toxin

— Repeat debridement as needed

— Early enteral feeding via NG/OG tube once ileus resolves; advance to post-pyloric or PEG if prolonged

— Watch for refeeding syndrome

— Early PT/OT consultation, passive ROM to prevent contractures

— Speech/swallow eval prior to extubation

Airway management:

Ventilator strategy:

Wound debridement:

Nutrition:

Eye care: artificial tears, taping eyelids closed to prevent exposure keratopathy

Bowel/bladder: scheduled bowel regimen, indwelling Foley until autonomic recovery

VTE prophylaxis: LMWH (e.g., enoxaparin 40 mg SC daily) given prolonged immobility

Rehab integration:

CCS pearl: When CCS clock advances, your order set should include: ICU admit, intubate/ventilate, NG tube, Foley, DVT ppx, eye lubrication, enteral nutrition, HBAT or BIG-IV, ID consult, neurology consult, surgery consult (wound), public health notification

Board pearl: Most botulism deaths today are from respiratory failure or nosocomial complications, not the toxin itself — meticulous ICU care drives survival >95%

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher baseline rates of ptosis, dysphagia, and weakness — may delay recognition

— Reduced respiratory reserve → earlier intubation threshold

— More susceptible to ICU complications: delirium, pressure injuries, deconditioning, VAP, C. difficile

— Polypharmacy: review for drugs that potentiate neuromuscular blockade (aminoglycosides, fluoroquinolones, macrolides, magnesium, calcium channel blockers, beta-blockers) and hold when feasible

— Anticholinergic burden worsens ileus, urinary retention, and delirium — deprescribe oxybutynin, diphenhydramine, TCAs during admission

— Antitoxin (HBAT, BIG-IV) does not require renal dose adjustment

— Adjust concurrent medications: penicillin G renal-dosed; LMWH switched to unfractionated heparin or dose-reduced if CrCl <30; avoid nephrotoxic combinations

— Monitor for contrast use if imaging mimics being worked up

— No specific antitoxin adjustment

— Adjust sedatives (avoid prolonged benzodiazepines), acetaminophen dosing (<2 g/day in cirrhosis)

— Coagulopathy increases procedural bleeding risk (debridement, tracheostomy)

— Higher risk of secondary nosocomial infections; lower threshold for cultures

— Consider longer antibiotic courses if wound botulism with concurrent bacteremia

— Lower baseline respiratory reserve; intubate earlier

— Avoid steroids unless required (do not improve botulism and increase infection risk)

Elderly patients:

Renal impairment:

Hepatic impairment:

Immunocompromised hosts:

Patients with neuromuscular comorbidities (MG, ALS, prior stroke):

Step 3 management: In an elderly patient with foodborne botulism, perform a medication reconciliation on admission to remove NMJ-potentiating drugs; this single step often prevents intubation in borderline cases

Board pearl: Functional baseline before paralysis predicts disposition — frail elderly often require SNF or LTACH rather than home after extubation

Special Populations — Pregnancy and Pediatrics

— Botulinum toxin is large (~150 kDa) and does not cross the placenta in clinically significant amounts; fetal botulism essentially does not occur

— HBAT can be given in pregnancy — benefits outweigh theoretical risks; counsel about equine product reactions

— Manage maternal respiratory failure aggressively; maternal hypoxia is the principal fetal threat

— Left lateral decubitus positioning, fetal monitoring per gestational age, MFM consultation

— Avoid teratogenic adjuncts (e.g., metronidazole generally acceptable; aminoglycosides avoided for both teratogenic and NMJ reasons)

— Most common form in the US (~70–100 cases/yr); peak 2–4 months

— Avoid honey before age 1 — central anticipatory guidance point

— Treatment: BIG-IV (BabyBIG) as early as possible; antibiotics not routine

— Aminoglycosides contraindicated — worsen paralysis

— Recovery may take weeks to months; long-term neurologic outcomes generally excellent

— Wound botulism rare in pediatrics; consider in adolescent IV drug users

— Foodborne pediatric cases follow same principles as adults; HBAT is approved for ≥1 yr

— Toxin does not transfer in breast milk in clinically meaningful amounts; breastfeeding can continue in maternal cases (with pumping support if intubated) — supports infant gut flora maturation, which is itself protective against infant botulism

Pregnancy:

Infant botulism (<12 months):

Older children:

Breastfeeding:

Key distinction: Honey and corn syrup are the classic infant exposure questions — but most US infant botulism cases come from environmental spore inhalation/ingestion (dust, soil), especially in California; absence of honey history doesn't rule it out

Step 3 management: Any floppy infant with constipation, poor feeding, and ptosis → call CIBTPP (510-231-7600) for BabyBIG and admit to PICU; do not delay for stool toxin results

Complications and Adverse Outcomes

— Mechanical ventilation in 20–60% of foodborne, ~50% of wound, ~50–70% of infant cases

— Mean duration: weeks to months; some require tracheostomy

— Frequent need for empiric antibiotics (avoid aminoglycosides; use ceftriaxone, piperacillin-tazobactam, or per local antibiogram)

— Ileus, urinary retention, orthostatic hypotension, anhidrosis, fixed heart rate

— Bowel pseudo-obstruction can persist for weeks

— Ventilator-associated pneumonia, central line infections, C. difficile

— Pressure injuries, deep vein thrombosis/PE

— ICU-acquired weakness/critical illness myopathy — can be hard to distinguish from prolonged botulism recovery

— Anaphylaxis (~2%), serum sickness (~3–9%) 1–3 weeks after equine HBAT

— Infusion reactions to BIG-IV (usually mild)

— Polymicrobial soft tissue infection, necrotizing fasciitis, abscess, endocarditis

— Currently <5–10% with modern ICU care; historically up to 60%

— Highest risk in elderly, those with delayed antitoxin (>24 h from symptom onset), and patients requiring prolonged ventilation

— Months to over a year; symmetric, slow re-sprouting of motor end plates

— Fatigue, dyspnea on exertion, autonomic symptoms can persist

Respiratory failure — the dominant complication

Aspiration pneumonia from impaired swallow and cough

Autonomic complications:

ICU-acquired complications:

Ophthalmologic: exposure keratopathy from incomplete eyelid closure → corneal ulceration if eye care neglected

Psychiatric: ICU delirium, post-ICU PTSD, depression — particularly after prolonged "locked-in" awareness during paralysis

Antitoxin-related:

Wound botulism specifically:

Mortality:

Recovery:

Board pearl: Patients are often paralyzed but fully aware — provide adequate analgesia, sedation as needed, and frequent communication to mitigate psychological trauma

Step 3 management: Monitor for serum sickness 7–21 days post-HBAT with rash, arthralgias, fever — treat with NSAIDs/short-course steroids

When to Escalate Care — ICU, Consults, Transfer

— Even if currently ambulatory, paralysis can progress rapidly over hours

— FVC <30% predicted or <15–20 mL/kg

— NIF worse than −30 cmH₂O

— Single-breath count <20

— Inability to handle secretions / absent gag

— Rapidly progressive bulbar weakness

— Hypoxia or hypercapnia (late and ominous)

— Neurology: confirm clinical syndrome, perform/interpret EMG, exclude mimics

— Infectious disease: antitoxin coordination, antibiotic selection in wound cases

— Critical care: airway, ventilator management

— Surgery: wound debridement in wound botulism

— Public health / CDC: mandatory, immediate

— Pediatrics / neonatology for infant cases; MFM if pregnant

— Speech-language pathology for swallow evaluation before extubation

— Rehab medicine / PT-OT early for prolonged recovery planning

— Community hospitals without ICU ventilator capacity or pediatric ICU should transfer to tertiary center after stabilization and securing antitoxin

— Coordinate with state health department; antitoxin may be released to either facility

— Use ground vs. air transport based on respiratory stability; pre-emptive intubation prior to transport is usually safer than mid-transport airway loss

— Botulism is a nationally notifiable disease — report to state/local health department immediately (often within 24 h, sometimes faster for outbreak triggers)

— Coordinate with FDA/USDA for implicated commercial foods

Every suspected botulism case warrants ICU-level care

Indications for immediate intubation:

Required consultations:

Transfer considerations:

Reporting obligations:

CCS pearl: On the CCS case, advancing the clock without ICU admission, intubation readiness, and public health notification will cost points — these orders should appear in the first 30 simulated minutes

Key Differentials — Other Neuromuscular Disorders

— Ascending (vs descending) symmetric weakness; areflexia is early and prominent

— Often post-infectious (Campylobacter, CMV, EBV, Zika, recent vaccination)

— CSF: albuminocytologic dissociation (elevated protein, normal WCC) after ~1 wk

— EMG: demyelinating pattern, prolonged distal latencies, conduction block

— Miller Fisher: ophthalmoplegia, ataxia, areflexia (+anti-GQ1b Ab) — can mimic botulism, but areflexia and ataxia distinguish

— Treatment: IVIG or plasmapheresis (not antitoxin)

— Fatigable weakness worsening through the day; ptosis, diplopia, fluctuating bulbar/limb weakness

— Pupils spared; sensation normal

— EMG: decrement on low-frequency repetitive stimulation

— Anti-AChR or anti-MuSK antibodies; ice pack test improves ptosis

— Treatment: pyridostigmine, immunosuppression, IVIG/plex in crisis

— Presynaptic Ab against voltage-gated Ca²⁺ channels; paraneoplastic (small cell lung Ca) in ~60%

— Proximal weakness that improves with activity, hyporeflexia that improves post-exercise, autonomic features (dry mouth)

— EMG: incremental response to high-frequency stimulation (shared with botulism), but clinical tempo is subacute/chronic

— Ascending flaccid paralysis; resolves with tick removal; look in scalp/hairline

— Common in children in tick-endemic regions

— Cholinergic excess (SLUDGE/DUMBBELS) — opposite of botulism's anticholinergic-like picture

— Miosis, bronchorrhea, diaphoresis

Guillain-Barré syndrome (GBS) — esp. Miller Fisher variant

Myasthenia gravis

Lambert-Eaton myasthenic syndrome (LEMS)

Tick paralysis

Organophosphate / nerve agent poisoning

Key distinction: Pupils — dilated/sluggish in botulism, normal in GBS/MG, constricted in organophosphates

Key Differentials — Non-Neuromuscular Mimics

— Acute cranial nerve deficits, quadriparesis, locked-in syndrome possible

— Usually asymmetric, with altered consciousness, crossed signs, and abnormal MRI/CTA

— Time-critical — get CT/CTA head and neck if any uncertainty

— Pharyngeal pseudomembrane, palatal weakness, then descending paralysis weeks later

— Unvaccinated travelers from endemic regions

Brainstem stroke (basilar artery thrombosis)

Myasthenic crisis (covered above) — overlapping bulbar/respiratory picture

Diphtheritic neuropathy

Heavy metal poisoning (thallium, arsenic): painful sensory neuropathy + GI + alopecia — sensory involvement helps exclude botulism

Hypermagnesemia: NMJ blockade, areflexia, weakness; check Mg level (esp. preeclampsia treatment, renal failure with Mg-containing antacids)

Hypokalemic / hyperkalemic periodic paralysis: episodic, K-mediated; check electrolytes

Wernicke encephalopathy: ophthalmoplegia + ataxia + confusion — confusion distinguishes from botulism

Conversion disorder / functional neurologic disorder: inconsistent exam, normal NIF, no autonomic features — diagnosis of exclusion after ruling out organic causes

Snakebite envenomation (elapid neurotoxins): geographic clue, bite mark, rapid descending paralysis — can closely mimic botulism but with envenomation history

Drug-induced: aminoglycosides + neuromuscular disease, prolonged neuromuscular blocker effect, magnesium overdose

Acute intermittent porphyria: motor neuropathy with abdominal pain, psychiatric features, dark urine — sensory involvement and tempo differ

Sepsis with critical illness polyneuromyopathy: subacute in ICU patients; not a presenting diagnosis

Board pearl: Any patient with bilateral cranial nerve palsies should get CT/CTA brain to exclude basilar artery thrombosis before settling on botulism — both are time-critical but treatments are completely different

Step 3 management: When the differential includes both stroke and botulism, imaging first, antitoxin call simultaneously — they are parallel, not sequential

Secondary Prevention and Discharge Planning

— Use pressure canning (not boiling water bath) for low-acid foods (vegetables, meats, fish); follow USDA Complete Guide to Home Canning

— Discard bulging, leaking, foul-smelling, or damaged cans

— Boil home-canned foods 10 minutes before eating — heat-labile toxin destroyed at 85°C for 5 min

— Refrigerate garlic/herb-in-oil mixtures; commercial garlic-in-oil contains acidifiers

— Store potatoes baked in foil hot or refrigerated (anaerobic foil-wrap is a known vehicle)

— Smoked/fermented fish (esp. Alaska Native communities) — refrigerate; education in culturally appropriate manner

— IVDU: harm reduction — stop or transition to opioid use disorder treatment (buprenorphine, methadone, naltrexone); needle exchange programs; avoid skin-popping; wound hygiene; Tdap update

— Refer to addiction medicine; offer naloxone Rx for overdose prevention

— No honey or corn syrup before age 1 — counsel at every well-child visit through 12 months

— In high-risk regions (CA, PA, UT), counsel on dust/soil exposure

— Breastfeeding may be protective (gut flora development)

— Stop drugs that prolong NMJ recovery (aminoglycosides, magnesium-containing OTCs)

— Continue VTE prophylaxis until ambulating

— Bowel regimen (PEG-3350) while autonomic recovery continues

— Eye lubrication PRN

— No human botulism vaccine routinely available (a pentavalent investigational vaccine exists for lab workers/military)

— Update Tdap, flu, pneumococcal, COVID per routine

Foodborne botulism — patient and family education:

Wound botulism prevention:

Infant botulism prevention:

Discharge medication review:

Vaccinations:

Board pearl: Boiling for 10 minutes destroys preformed botulinum toxin — a critical Step 3 prevention pearl for foodborne disease

Follow-Up, Monitoring, and Rehabilitation

— Symmetric, slow improvement from rostral to caudal (reverse of paralysis onset)

— Recovery requires regeneration of presynaptic terminals — weeks to >12 months

— Fatigue, dry mouth, constipation, exertional dyspnea can persist for months

— Home with outpatient PT/OT if independent ADLs and ambulation

— Inpatient rehab for residual weakness with rehab potential

— LTACH for ventilator-dependent or tracheostomy patients

— SNF for elderly/frail with prolonged deconditioning

— Primary care: within 1–2 weeks post-discharge, then monthly until baseline

— Neurology: at 2–4 weeks, then every 1–3 months until stable

— Pulmonology if persistent dyspnea or trach in place

— Speech-language pathology for residual dysphagia/dysarthria

— Ophthalmology if persistent diplopia or exposure keratopathy

— Pediatrics: monthly developmental assessments after infant botulism through 1 year

— Addiction medicine follow-up for wound botulism / IVDU patients

— Functional status, ambulation distance, swallow safety

— Spirometry (FVC) at follow-up visits if prolonged weakness

— Watch for serum sickness 1–3 weeks post-HBAT — fever, rash, arthralgias, proteinuria

— Screen for post-ICU syndrome: cognitive, psychiatric, physical dimensions

— Set realistic expectations: recovery is measured in months, not days

— Anticipatory guidance on fatigue management and pacing

— Mental health screening (PHQ-9, GAD-7) at each visit

— Driving: defer until vision (diplopia) and reflexes recover

Post-acute trajectory:

Discharge disposition:

Follow-up schedule:

Monitoring parameters:

Counseling:

Step 3 management: Schedule a proactive 7–14 day post-discharge call to screen for serum sickness symptoms after HBAT — early oral steroid taper prevents complicated immune complex disease

Board pearl: Recovery is slow but typically complete — reassure patients and families

Ethical, Legal, and Patient Safety Considerations

— Botulism is a nationally notifiable disease — clinicians must report immediately (often within hours) to state/local health department

— Reporting overrides standard HIPAA privacy concerns under public health exception

— Failure to report can carry licensure and legal consequences

— A patient with isolated cranial nerve palsies but intact cognition can consent for intubation; document carefully

— A fully paralyzed but alert patient may communicate via blink codes or letter boards — establish a communication method and obtain consent for ongoing procedures (tracheostomy, PEG)

— If communication impossible and decision urgent, proceed under emergency doctrine and engage surrogate decision maker per state hierarchy

— Botulinum toxin is a CDC Category A bioterrorism agent

— Cluster of cases without common food source, atypical serotypes (C, D, F), or inhalational presentation should trigger notification to public health and law enforcement

— Maintain chain of custody for samples

— Avoid stigmatizing language in documentation

— Offer substance use disorder treatment during admission — missed opportunity is an ethical lapse

— Confidentiality around drug use, balanced with mandatory reporting of the infectious disease

— Handoff from ICU to floor to LTACH/rehab is high-risk for missed medications (eye lubrication, bowel regimen), missed follow-up for serum sickness, and missed antitoxin documentation

— Use structured handoff (e.g., I-PASS) and explicit medication reconciliation

— Anticipatory guidance to avoid honey before age 1 is a quality-of-care measure tracked in pediatrics

— Trace and warn co-ingesters; coordinate with FDA for product recalls

Mandatory public health reporting:

Informed consent edge cases:

Bioterrorism considerations:

Wound botulism in IV drug users:

Transitions of care risk:

Honey and infant botulism:

Patient safety in food outbreaks:

Step 3 management: Cluster of 3 patients with descending paralysis after a church potluck → simultaneously report to state health dept, isolate suspect foods, identify and contact all attendees, and pre-position antitoxin for symptomatic contacts

High-Yield Associations and Rapid-Fire Clinical Facts

Toxin types: A, B, E most common human disease; A and B from soil; E from aquatic environments / fish

Type E classically: Alaska Native fermented fish/marine mammal preparations

Heat-labile toxin: destroyed by boiling 10 min at 85°C for 5 min — pressure canning needed for spores

Spores: heat-resistant, survive boiling; need >121°C (pressure canning) to kill

Mechanism: cleaves SNARE proteins (SNAP-25 [A, E, C], synaptobrevin/VAMP [B, D, F, G], syntaxin [C]) at presynaptic cholinergic terminals

"4 D's": diplopia, dysarthria, dysphonia, dysphagia

Classic exam picture: afebrile, alert, symmetric descending flaccid paralysis with dilated/sluggish pupils and preserved sensation

Infant botulism: floppy baby, constipation first, weak cry, poor suck, ptosis; honey, soil/dust; treat with BabyBIG

Wound botulism: black tar heroin skin-poppers; treat with HBAT + penicillin G + surgical debridement

Foodborne: home-canned low-acid foods, garlic-in-oil, baked potato in foil, fermented fish; treat with HBAT

Antitoxin source: state health department → CDC; BabyBIG from CIBTPP (CA)

EMG: incremental response to high-frequency repetitive stimulation (shared with LEMS)

CSF: normal (vs. GBS albuminocytologic dissociation)

Avoid: aminoglycosides, clindamycin, magnesium, succinylcholine cautiously — all worsen weakness

Antibiotics in foodborne/infant: not given (cell lysis releases more toxin)

Iatrogenic botulism: cosmetic/therapeutic injections — usually localized but systemic spread possible with high doses

Adult intestinal toxemia: rare adult counterpart of infant botulism — post-GI surgery, IBD, prior antibiotics

Mortality: now <5–10% with modern ICU care

Notifiable: report immediately; CDC EOC 770-488-7100

Board pearl: If the stem says "ate home-canned green beans + bilateral ptosis + dilated pupils + descending weakness," the answer is call public health for botulinum antitoxin — not IVIG, not plasmapheresis, not pyridostigmine

Board Question Stem Patterns

— Best next step: Notify state health department and administer equine heptavalent botulism antitoxin (HBAT) — do not wait for confirmatory testing

— Best next step: Admit PICU, supportive care, contact California Infant Botulism Treatment and Prevention Program for BIG-IV (BabyBIG); do NOT give aminoglycosides

— Best next step: HBAT, surgical debridement, then penicillin G (or metronidazole if allergic); ICU admission

— Best next step: Elective intubation before respiratory arrest

— Answer: GBS (not botulism); treat with IVIG or plasmapheresis

— Answer: After 12 months of age to prevent infant botulism

— Answer: Immediate reporting to local/state health department

Stem 1 — Foodborne classic: "48-yo woman presents with diplopia, dysphagia, and dry mouth 24 h after a family reunion where home-canned green beans were served; 2 family members are also symptomatic. Exam: bilateral ptosis, dilated sluggish pupils, descending weakness, afebrile."

Stem 2 — Infant: "5-week-old previously well infant with 3 days of constipation, poor feeding, weak cry; exam shows hypotonia, ptosis, sluggish pupils, decreased gag."

Stem 3 — Wound (IVDU): "32-yo with history of IV heroin use presents with diplopia, dysarthria, and progressive weakness; exam shows fluctuant abscess on forearm at injection site, descending paralysis."

Stem 4 — Pulmonary trajectory: "Patient with confirmed botulism on day 2, FVC dropping from 2.8 L to 1.2 L over 6 hours, NIF −18 cmH₂O."

Stem 5 — Differential: "Patient with ascending weakness, areflexia, recent diarrheal illness, CSF protein elevated."

Stem 6 — Prevention: "Mother asks when she can introduce honey to her 8-month-old."

Stem 7 — Public health: "ED physician diagnoses botulism; what is required?"

Board pearl: Common distractors include IVIG (wrong — that's GBS), pyridostigmine (wrong — myasthenia), and "wait for confirmatory testing" (always wrong — treat empirically)

One-Line Recap

Botulism is a clinical diagnosis of symmetric descending flaccid paralysis in an afebrile, alert patient with dilated pupils — treat empirically with antitoxin (HBAT for foodborne/wound, BIG-IV for infants), admit to ICU with serial respiratory monitoring, and report to public health immediately.

Recognize: 4 D's (diplopia, dysarthria, dysphonia, dysphagia) + descending symmetric flaccid weakness + dilated/sluggish pupils + preserved sensation and mentation; afebrile; antecedent home-canned food, wound/IVDU, or honey/dust in infant

Diagnose: Clinical — empiric treatment first; confirm with serum/stool/wound toxin assay and EMG (incremental response at high-frequency stim); CSF normal (vs GBS)

Treat: HBAT for foodborne/wound (≥1 yr), BabyBIG for infant <1 yr; add penicillin G + surgical debridement for wound; avoid aminoglycosides/clindamycin/magnesium; airway management with serial NIF/FVC and elective intubation before respiratory failure

Prevent and report: Boil home-canned food 10 min; pressure canning for low-acid foods; no honey before age 1; address IVDU; mandatory public health notification (CDC EOC 770-488-7100) — botulism is a Category A bioterrorism agent and a nationally notifiable disease

Step 3 management: Across all three forms — antitoxin first, supportive ICU care second, source control third, public health notification simultaneous — with proactive 1–2 week follow-up to screen for serum sickness after equine HBAT